ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,233 | -28.3% | 90,318 | -11.7% | 0.00% | – |
| Q2 2023 | $686,708 | -10.5% | 102,341 | +17.8% | 0.00% | – |
| Q1 2023 | $766,956 | +61.6% | 86,858 | +39.8% | 0.00% | – |
| Q4 2022 | $474,719 | +146.0% | 62,136 | +130.1% | 0.00% | – |
| Q3 2022 | $193,000 | -5.9% | 27,005 | +6.8% | 0.00% | – |
| Q2 2022 | $205,000 | -70.3% | 25,280 | -49.1% | 0.00% | – |
| Q1 2022 | $690,000 | -50.4% | 49,652 | +0.1% | 0.00% | – |
| Q4 2021 | $1,392,000 | -21.3% | 49,602 | -4.7% | 0.00% | -100.0% |
| Q3 2021 | $1,769,000 | +183.0% | 52,058 | +240.3% | 0.00% | – |
| Q2 2021 | $625,000 | -29.4% | 15,297 | -30.4% | 0.00% | – |
| Q1 2021 | $885,000 | -34.8% | 21,981 | -4.3% | 0.00% | – |
| Q4 2020 | $1,358,000 | +4.7% | 22,967 | -13.9% | 0.00% | – |
| Q3 2020 | $1,297,000 | +16.5% | 26,678 | +15.9% | 0.00% | – |
| Q2 2020 | $1,113,000 | +50.0% | 23,012 | -13.9% | 0.00% | – |
| Q1 2020 | $742,000 | +149.8% | 26,718 | +169.1% | 0.00% | – |
| Q4 2019 | $297,000 | -20.8% | 9,930 | -18.2% | 0.00% | – |
| Q3 2019 | $375,000 | – | 12,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |